As such, the potential impact rs553664 and/or rs536852 may have on AP-1 and/or the binding of other TFs could alter β-arrestin 1 expression and, consequently, any downstream functions of β-arrestin 1, including the transmission of receptor-mediated signals during ATD treatment or the scaffolding of proteins. This evidence concerns the gene FOS and Jeune syndrome.